Alpine Bank Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Alpine Bank Wealth Management's PFE Position: Q1 2026 in Review
Alpine Bank Wealth Management reduced its Pfizer (PFE) stake by 3.6% in Q1 2026, selling an estimated $32.2K and leaving 32,090 shares worth $901K. The position accounts for 0.13% of the portfolio, ranked #88.
Alpine Bank Wealth Management first reported a position in PFE in Q3 2024 and has held it in 6 quarters since. The position peaked at $928K in Q3 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Alpine Bank Wealth Management held 32,090 shares of Pfizer worth $901K as of Q1 2026.
- Alpine Bank Wealth Management sold 1,209 Pfizer shares in Q1 2026, an estimated $32.2K.
- Pfizer made up 0.13% of Alpine Bank Wealth Management's portfolio in Q1 2026, its #88 holding.
- Alpine Bank Wealth Management first reported a position in Pfizer in Q3 2024 and has held it in 6 quarters since.
- Alpine Bank Wealth Management's Pfizer position peaked at $928K in Q3 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Alpine Bank Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.